EU-OPENSCREEN has secured funding from the European Union for the IMPULSE project (Grant Agreement No. 101132028), short for IMProving User experience, Long-term sustainability, and Services of…
The EU-funded project Fragment-Screen [1] aims to develop innovative instrumentation, workflows, and methodologies for fragment-based drug discovery (FBDD). In a joint effort by four ESFRI Landmark…
EU-OPENSCREEN is pleased to announce that Philip Gribbon has been appointed as its Director General and wishes him well in his new role. Philip is known to many in our community for his time as…
Use our EU-OPENSCREEN services to advance your cancer research within the recently published canSERV open call for transnational service provision which is now open for applications
The paper from our colleagues at Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) reports the structural evaluation and molecular determinants for selective PI3K-C2α inhibition by a…
Register now for our Autumn Online Training School and participate in three exciting days of science. Get ready to explore chemical biology and early drugdiscovery and engage with leading experts in…
Are you interested to to identify novel biologically active compounds for crop protection from pests or as physiological agents to promote crop productivity in changing environments or for veterinary…
E3 ligases are enzymes that play a critical role in ubiquitin-mediated protein degradation and are involved in various cellular processes. Pharmacophore analysis is a useful approach for predicting E3…
Our Spanish medicinal chemistry partner site CSIC has published a paper on the importance of chemical libraries for drug discovery. The paper analyses the Medicinal and Biological Chemistry (MBC) and…
